Related Experiment Video
Updated: Jun 12, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
Published on: October 11, 2013
Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice
Adam D Kenney1,2, Ashley Zani1,2, Jeffrey Kawahara1,2
1Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA.
Abstract:
Interferon-induced transmembrane protein 3 (IFITM3) is an antiviral protein that alters cell membranes to block fusion of viruses. Conflicting reports identified opposing effects of IFITM3 on SARS-CoV-2 infection of cells, and its impact on viral pathogenesis in vivo remains unclear. Here, we show that IFITM3 knockout (KO) mice infected with SARS-CoV-2 experience extreme weight loss and lethality compared to mild infection in wild-type (WT) mice. KO mice have higher lung viral titers and increases in inflammatory cytokine levels, immune cell infiltration, and histopathology. Mechanistically, we observe disseminated viral antigen staining throughout the lung and pulmonary vasculature in KO mice, as well as increased heart infection, indicating that IFITM3 constrains dissemination of SARS-CoV-2. Global transcriptomic analysis of infected lungs shows upregulation of gene signatures associated with interferons, inflammation, and angiogenesis in KO versus WT animals, highlighting changes in lung gene expression programs that precede severe lung pathology and fatality. Our results establish IFITM3 KO mice as a new animal model for studying severe SARS-CoV-2 infection and overall demonstrate that IFITM3 is protective in SARS-CoV-2 infections in vivo.
Insights
Interferon-induced transmembrane protein 3 (IFITM3) protects against severe SARS-CoV-2 infection. IFITM3 knockout mice showed increased lethality and viral spread, highlighting IFITM3's protective role in vivo.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Interferon-induced transmembrane protein 3 (IFITM3) is an antiviral protein.
- Previous studies showed conflicting roles for IFITM3 in SARS-CoV-2 infection.
- The in vivo role of IFITM3 in SARS-CoV-2 pathogenesis was unclear.
Purpose of the Study:
- To investigate the role of IFITM3 in SARS-CoV-2 infection in vivo.
- To establish a mouse model for studying severe SARS-CoV-2 infection.
Main Methods:
- Generation and use of IFITM3 knockout (KO) mice.
- Infection of wild-type (WT) and KO mice with SARS-CoV-2.
- Analysis of weight loss, lethality, viral titers, cytokine levels, immune cell infiltration, histopathology, viral antigen distribution, and lung transcriptomics.
Main Results:
- IFITM3 KO mice exhibited severe weight loss and lethality post-SARS-CoV-2 infection compared to WT mice.
- KO mice showed higher lung viral loads, increased inflammation, immune cell infiltration, and lung pathology.
- IFITM3 deficiency led to viral dissemination in the lungs, vasculature, and heart.
- Transcriptomic analysis revealed upregulated interferon, inflammation, and angiogenesis pathways in KO mice lungs.
Conclusions:
- IFITM3 constrains SARS-CoV-2 dissemination in vivo.
- IFITM3 knockout mice serve as a valuable model for severe SARS-CoV-2 infection research.
- IFITM3 plays a protective role against SARS-CoV-2 pathogenesis.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly

